Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 277 Records) |
| Query Trace: Sarcoma and Kras[original query] |
|---|
| Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China. OncoTargets and therapy 2022 9 15 1021-1032. Gu Guomin, Yu Bo, Wan Hua, Lu Suqiong, Zhu Xiaodan, Zhao Yan, Fuxi Yujing, Liu Chunli |
| Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. Thoracic cancer 2022 Sep . Chang Geyun, Li Weihua, Bai Hua, Duan Jianchun, Wang Zhijie, Du Xinyang, Yu Ruofei, Wang Yaxi, Wang Minghao, Zhu Yixiang, Zhang Xue, Li Li, Wan Rui, Wang J |
| A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab. Translational lung cancer research 2022 9 11 (8): 1619-1630. Shen Yinchen, Li Jiaqi, Qiang Huiping, Lei Yuqiong, Chang Qing, Zhong Runbo, Stella Giulia Maria, Gelsomino Francesco, Kim Yeon Wook, Abed Afaf, Qian Jialin, Chu Tianqi |
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study. Clinical lung cancer 2022 Jul . Mazzaschi Giulia, Perrone Fabiana, Minari Roberta, Verzè Michela, Azzoni Cinzia, Bottarelli Lorena, Pluchino Monica, Armillotta Maria Pia, Ubaldi Annalisa, Altimari Annalisa, Gruppioni Elisa, Sperandi Francesca, Andrini Elisa, Guaitoli Giorgia, Bettelli Stefania, Longo Lucia, Bertolini Federica, Barbieri Fausto, Pagano Maria, Bonelli Candida, Tagliavini Elena, Nicoli Davide, Ubiali Alessandro, Zangrandi Adriano, Trubini Serena, Proietto Manuela, Gnetti Letizia, Tiseo Marcello, |
| Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles. Clinical lung cancer 2022 Jul . Hsu Robert, Herrmann Amanda, Gaur Kush, Xia Bing, Nieva Jorge |
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101. Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li |
| Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia. Oncology letters 2022 6 24 (1): 225. Kataoka Toshiaki, Okudela Koji, Matsumura Mai, Baba Tomohisa, Kitamura Hideya, Arai Hiromasa, Suzuki Takeshisa, Koike Chihiro, Mutsui Hideaki, Sekiya Motoki, Sugiyama Misaki, Takemura Tamiko, Iwasawa Tae, Ogura Takashi, Ohashi Kenic |
| The Effect of the Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Proto-Oncogene, GTPase Genetic Polymorphism on the Safety and Efficacy of Bevacizumab Combination Treatment Regimens for Patients with Nonsquamous, Non-Small Cell Lung Cancer with Brain Metastases. Genetic testing and molecular biomarkers 2022 5 26 (5): 290-297. Song Zizheng, Ren Guanying, Wang Xiaolei, Hu Li |
| Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma. Cureus 2022 Apr 14 (4): e24175. Yekedüz Emre, Akbulut Hakan, Utkan Güngör, Ürün Yüks |
| The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer. World journal of oncology 2022 5 13 (2): 84-95. Zhu Dao Qi, Liu Ying, Yu Zhi Jian, Zhang Ru Hua, Li Ai Wu, Gong Feng Ying, Wang Wei, Xiao Wei, Fan Q |
| Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Hepatology (Baltimore, Md.) 2022 May . Zhou Jun, Sun Yongkun, Zhang Wen, Yuan Jiajia, Peng Zhi, Wang Wei, Gong Jifang, Yang Lin, Cao Yanshuo, Zhao Hong, Chen Chao, Wang Weifeng, Shen Lin, Zhou Aipi |
| The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
| RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (14): 3091-3103. Hunihan Lisa, Zhao Dejian, Lazowski Heather, Li Man, Qian Yuping, Abriola Laura, Surovtseva Yulia V, Muthusamy Viswanathan, Tanoue Lynn T, Rothberg Bonnie E Gould, Schalper Kurt A, Herbst Roy S, Wilson Frederick |
| Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery. Annali italiani di chirurgia 2022 3 92 65-77. Aziret Mehmet, Subasi Ozkan, Bilir Cemil, Tozlu Mukaddes, Alt?ntoprak Fatih, Karaman Kerem, Ercan Metin, Celebi Feh |
| Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer. Cancer medicine 2022 3 11 (16): 3126-3135. Hayashi Takaomi, Yoshida Yoichiro, Yamada Teppei, Tanaka Keita, Shimaoka Hideki, Kajitani Ryuji, Munechika Taro, Nagano Hideki, Matsumoto Yoshiko, Komono Akira, Sakamoto Ryohei, Aisu Naoya, Yoshimatsu Gumpei, Yoshimura Fumihiro, Hasegawa Sugu |
| Kirsten rat sarcoma (KRAS) oncogene mutation predicts magnitude of response and outcomes in hepatic arterial infusion pump therapy of unresectable colorectal liver metastases. Journal of gastrointestinal oncology 2022 3 13 (1): 163-170. Kolbeinsson Hordur M, Preihs Randa, Bengel Alexandra, Chandana Sreenivasa, Assifi M Mura, Chung Mathew H, Wright G Pa |
| Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer. Frontiers in oncology 2022 12 12 1055019. Lavacchi Daniele, Fancelli Sara, Roviello Giandomenico, Castiglione Francesca, Caliman Enrico, Rossi Gemma, Venturini Jacopo, Pellegrini Elisa, Brugia Marco, Vannini Agnese, Bartoli Caterina, Cianchi Fabio, Pillozzi Serena, Antonuzzo Loren |
| High frequency of KRAS and EGFR mutation profiles in BRAF-negative thyroid carcinomas in Indonesia. BMC research notes 2022 12 15 (1): 369. Heriyanto Didik Setyo, Laiman Vincent, Limantara Nikko Vanda, Anantawikrama Widyan Putra, Yuliani Fara Silvia, Cempaka Rita, Anwar Sumadi Lukm |
| Clinical predictors of treatment efficacy and a prognostic nomogram in patients with lung adenocarcinoma receiving immune checkpoint inhibitors: a retrospective study. Journal of thoracic disease 2022 11 14 (10): 4096-4112. Hu Fang, Peng Jin, Niu Yanjie, Mao Xiaowei, Zhao Yizhuo, Jiang Liy |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma. Thoracic cancer 2023 4 . Li Hong-Shuai, Liu Cheng-Ming, Wang Y |
| Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark. PloS one 2023 4 18 (4): e0284037. Dalvi Tapashi, Nørgaard Mette, Fryzek Jon P, Movva Naimisha, Pedersen Lars, Pham Hansen Hanh, Walker Jill, Midha Anita, Shire Norah, Boothman Anne-Marie, Rigas James, Mellemgaard Anders, Rasmussen Torben R, Hamilton-Dutoit Stephen, Cronin-Fenton Deird |
| Efficacy of immunotherapy as second-line or later-line therapy and prognostic significance of KRAS and/or TP53 mutations in advanced non-small cell lung cancer patients. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023 4 . Liu Jingya, Gao Jiani |
| Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients. European review for medical and pharmacological sciences 2023 3 27 (4): 1480-1486. Dan N V, Phuong P C, Thai P V, Nguyen N H, Loi N T, Cong B |
| USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune checkpoint inhibitors in lung cancer. Journal of Zhejiang University. Science. B 2023 2 24 (2): 143-156. Yang Dexin, Feng Yuqin, Lu Haohua, Chen Kelie, Xu Jinming, Li Peiwei, Wang Tianru, Xia Dajing, Wu Yih |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| The impact of RAS mutation on the treatment strategy of colorectal cancer. Medicine and pharmacy reports 2023 2 96 (1): 5-15. Pirvu Edvina Elena, Severin Emilia, Ni?? Irina, Toma ?tefania Andre |
| Blood Liquid Biopsy in an Advanced Medullary Thyroid Carcinoma: A Case Study with Rearranged during Transfection Heterogeneity. Pathobiology : journal of immunopathology, molecular and cellular biology 2023 2 1-7. Gumà Josep, Peña Karla Beatríz, Riu Francesc, Lucia-Gozálvez Clara, Vidaller Ana, Maldonado Vanesa, Parada Dav |
| Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma. Applied immunohistochemistry & molecular morphology : AIMM 2023 1 31 (3): 181-188. Chibbar Rajni, Foerstner Sabrina, Suresh Janarathnee, Chibbar Richa, Piche Alexandre, Kundapur Deeksha, Kanthan Rani, Kundapur Vijayanand, Lee Cheng Han, Agrawal Anita, Lai Raymo |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: